KAYA, H. Et Al. 2024. Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study. EURASIAN JOURNAL OF PULMONOLOGY , no.1 , 41-50.

KAYA, H., ÖKSÜZLER KIZILBAY, G., ILGAZLI, A. H., & ÖZGÜR, E. G., (2024). Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study. EURASIAN JOURNAL OF PULMONOLOGY , no.1, 41-50.

KAYA, HÜSEYİN Et Al. "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study," EURASIAN JOURNAL OF PULMONOLOGY , no.1, 41-50, 2024

KAYA, HÜSEYİN Et Al. "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study." EURASIAN JOURNAL OF PULMONOLOGY , no.1, pp.41-50, 2024

KAYA, H. Et Al. (2024) . "Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study." EURASIAN JOURNAL OF PULMONOLOGY , no.1, pp.41-50.

@article{article, author={HÜSEYİN KAYA Et Al. }, title={Tocilizumab in hospitalized patients with severe COVID-19 pneumonia: A single-center observational study}, journal={EURASIAN JOURNAL OF PULMONOLOGY}, year=2024, pages={41-50} }